Cargando…
Management of hypersensivity pneumonitis
Hypersensitivity pneumonitis (HP) is an interstitial lung disease due to a combined type III and IV reaction with a granulomatous inflammation, caused by cytotoxic delayed hypersensitivity lymphocytes, in a Th1/Th17 milieu, chaperoned by a deficient suppressor function of T regulatory cells. Skewing...
Autores principales: | Agache, Ioana O, Rogozea, Liliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585806/ https://www.ncbi.nlm.nih.gov/pubmed/23374544 http://dx.doi.org/10.1186/2045-7022-3-5 |
Ejemplares similares
-
Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
por: Agache, Ioana, et al.
Publicado: (2017) -
Critical Points on the Use of Biologicals in Allergic Diseases and Asthma
por: Agache, Ioana, et al.
Publicado: (2019) -
Dysfunctional breathing phenotype in adults with asthma - incidence and risk factors
por: Agache, Ioana, et al.
Publicado: (2012) -
COVID-19 : le taux de troponine I hypersensible prédit-il la mortalité ?
por: Fekih, W., et al.
Publicado: (2022) -
Diagnosis, course and management of hypersensitivity pneumonitis
por: Hamblin, Mark, et al.
Publicado: (2022)